- Home
- KPRX vs RVSN Comparison
KPRX vs RVSN Comparison
Compare KPRX & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- RVSN
- Stock Information
- Founded
- KPRX 1998
- RVSN 2016
- Country
- KPRX United States
- RVSN Israel
- Employees
- KPRX N/A
- RVSN N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RVSN
- Sector
- KPRX Health Care
- RVSN
- Exchange
- KPRX Nasdaq
- RVSN Nasdaq
- Market Cap
- KPRX 9.1M
- RVSN 6.6M
- IPO Year
- KPRX N/A
- RVSN 2022
- Fundamental
- Price
- KPRX $2.82
- RVSN $0.32
- Analyst Decision
- KPRX Strong Buy
- RVSN
- Analyst Count
- KPRX 1
- RVSN 0
- Target Price
- KPRX $10.00
- RVSN N/A
- AVG Volume (30 Days)
- KPRX 1.4M
- RVSN 583.0K
- Earning Date
- KPRX 08-08-2025
- RVSN 07-07-2025
- Dividend Yield
- KPRX N/A
- RVSN N/A
- EPS Growth
- KPRX N/A
- RVSN N/A
- EPS
- KPRX N/A
- RVSN N/A
- Revenue
- KPRX $20,000.00
- RVSN $1,300,000.00
- Revenue This Year
- KPRX N/A
- RVSN $1,861.54
- Revenue Next Year
- KPRX N/A
- RVSN N/A
- P/E Ratio
- KPRX N/A
- RVSN N/A
- Revenue Growth
- KPRX N/A
- RVSN 815.49
- 52 Week Low
- KPRX $2.51
- RVSN $0.27
- 52 Week High
- KPRX $4.86
- RVSN $2.72
- Technical
- Relative Strength Index (RSI)
- KPRX 40.86
- RVSN 41.17
- Support Level
- KPRX $2.87
- RVSN $0.32
- Resistance Level
- KPRX $3.22
- RVSN $0.36
- Average True Range (ATR)
- KPRX 0.18
- RVSN 0.03
- MACD
- KPRX -0.03
- RVSN -0.00
- Stochastic Oscillator
- KPRX 21.20
- RVSN 41.74
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.